Good evening :)
Place Order
Add to Watchlist

Emmessar Biotech and Nutrition Ltd

EMMESSA Share Price

30.410.00% (+0.00)

EMMESSA Share Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹16 cr, stock is ranked 4,227
High RiskStock is 4.94x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹16 cr, stock is ranked 4,227
High RiskStock is 4.94x as volatile as Nifty

EMMESSA Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
21.412.22—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
49.276.300.54%

EMMESSA Analyst Ratings & Forecast

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

EMMESSA Company Profile

Emmessar Biotech and Nutrition Ltd operates in the healthcare sector, manufacturing and trading a diverse range of products addressing various health concerns, including dermatology and muscular pains.

EMMESSA Similar Stocks (Peers)

Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
44.07
1Y Return
7.04%
Buy Reco %
88.24
Cipla Ltd
CIPLA
PE Ratio
28.93
1Y Return
3.66%
Buy Reco %
72.73
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
65.78
1Y Return
24.12%
Buy Reco %
68.00
Mankind Pharma Ltd
MANKIND
PE Ratio
51.84
1Y Return
5.39%
Buy Reco %
81.25
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
17.40
1Y Return
7.09%
Buy Reco %
45.16
Compare with Peers

EMMESSA Forecasts

Price

Revenue

Earnings

EMMESSA Share Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

EMMESSA Company Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

EMMESSA Stock EPS (Earnings Per Share) Forecast

Hmm, looks like data is unavailable here. Please come back after some time

EMMESSA

Income

Balance Sheet

Cash Flow

EMMESSA Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 5.73%, vs industry avg of 9.04%

Constant Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 7.19%, vs industry avg of 15.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue2.243.592.521.934.878.462.282.772.552.48
Raw Materialssubtract0.590.970.510.552.242.640.130.450.171.62
Power & Fuel Costsubtract0.000.010.020.020.020.000.020.020.02
Employee Costsubtract0.310.380.410.580.580.640.770.840.96
Selling & Administrative Expensessubtract0.210.290.210.270.250.260.260.290.39
Operating & Other expensessubtract1.770.730.520.140.972.600.080.110.10
Depreciation/Amortizationsubtract0.030.010.050.080.060.060.090.090.100.08
Interest & Other Itemssubtract0.000.010.000.000.000.000.000.000.00—
Taxes & Other Itemssubtract-0.210.00-0.12-0.24-0.020.810.450.460.060.01
EPS-0.922.381.841.061.542.900.961.021.501.54
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

EMMESSA Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2015

Annual report

PDF
FY 2016

Annual report

PDF
FY 2017

Annual report

PDF
FY 2018

Annual report

PDF
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF
FY 2024

Annual report

PDF
 

EMMESSA Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Emmessar Biotech and Nutrition Ltd21.982.22—
Sun Pharmaceutical Industries Ltd44.076.290.77%
Cipla Ltd28.934.450.88%
Torrent Pharmaceuticals Ltd65.7815.890.87%

EMMESSA Stock Price Comparison

Compare EMMESSA with any stock or ETF
Compare EMMESSA with any stock or ETF
EMMESSA
Loading...

EMMESSA Shareholdings

EMMESSA Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

EMMESSA Institutional Holdings Trend

Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has decreased by 1.40%

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

EMMESSA Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding59.53%0.05%0.14%0.00%40.28%

Mar 2024

Jun 2024

Sep 2024

Dec 2024

EMMESSA Shareholding History

SepDec '23MarJunSepDec '240.00%0.00%0.00%0.00%0.00%0.00%

EMMESSA Insider Trades & Bulk Stock Deals

Loading...

smallcases containing EMMESSA stock

Looks like this stock is not in any smallcase yet.

EMMESSA Events

EMMESSA Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

EMMESSA has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

EMMESSA Dividends

Hmm, looks like data is unavailable here. Please come back after some time

EMMESSA Stock News & Opinions

Earnings
Emmessar Biotech & Nutrition standalone net profit declines 84.62% in the December 2024 quarter

Net profit of Emmessar Biotech & Nutrition declined 84.62% to Rs 0.02 crore in the quarter ended December 2024 as against Rs 0.13 crore during the previous quarter ended December 2023. Sales declined 69.70% to Rs 0.10 crore in the quarter ended December 2024 as against Rs 0.33 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales0.100.33 -70 OPM %-280.00-63.64 - PBDT0.150.32 -53 PBT0.130.30 -57 NP0.020.13 -85 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Emmessar Biotech & Nutrition announces board meeting date

Emmessar Biotech & Nutrition will hold a meeting of the Board of Directors of the Company on 6 February 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Emmessar Biotech & Nutrition standalone net profit rises 40.00% in the September 2024 quarter

Net profit of Emmessar Biotech & Nutrition rose 40.00% to Rs 0.28 crore in the quarter ended September 2024 as against Rs 0.20 crore during the previous quarter ended September 2023. Sales rose 325.00% to Rs 0.34 crore in the quarter ended September 2024 as against Rs 0.08 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales0.340.08 325 OPM %-23.53-275.00 - PBDT0.430.31 39 PBT0.410.29 41 NP0.280.20 40 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Emmessar Biotech & Nutrition to conduct board meeting

Emmessar Biotech & Nutrition will hold a meeting of the Board of Directors of the Company on 7 November 2024Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Emmessar Biotech & Nutrition schedules AGM

Emmessar Biotech & Nutrition announced that the 32th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live

6 months agoCapital Market - Live
Earnings
Emmessar Biotech & Nutrition standalone net profit rises 80.00% in the June 2024 quarter

Net profit of Emmessar Biotech & Nutrition rose 80.00% to Rs 0.09 crore in the quarter ended June 2024 as against Rs 0.05 crore during the previous quarter ended June 2023. Sales rose 14.29% to Rs 0.08 crore in the quarter ended June 2024 as against Rs 0.07 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales0.080.07 14 OPM %-350.00-400.00 - PBDT0.180.18 0 PBT0.160.16 0 NP0.090.05 80 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Emmessar Biotech & Nutrition to table results

Emmessar Biotech & Nutrition will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live

7 months agoCapital Market - Live

Frequently asked questions

  1. What is the share price of Emmessar Biotech and Nutrition Ltd (EMMESSA) today?

    The share price of EMMESSA as on 28th March 2025 is ₹30.41. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Emmessar Biotech and Nutrition Ltd (EMMESSA) share?

    The past returns of Emmessar Biotech and Nutrition Ltd (EMMESSA) share are
    • Past 1 week: -8.65%
    • Past 1 month: 1.37%
    • Past 3 months: -32.10%
    • Past 6 months: -28.19%
    • Past 1 year: 2.25%
    • Past 3 years: 18.71%
    • Past 5 years: 166.58%

  3. What are the peers or stocks similar to Emmessar Biotech and Nutrition Ltd (EMMESSA)?

    The peers or stocks similar to Emmessar Biotech and Nutrition Ltd (EMMESSA) include:

  4. What is the market cap of Emmessar Biotech and Nutrition Ltd (EMMESSA) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Emmessar Biotech and Nutrition Ltd (EMMESSA) is ₹16.49 Cr as of 28th March 2025.

  5. What is the 52 week high and low of Emmessar Biotech and Nutrition Ltd (EMMESSA) share?

    The 52-week high of Emmessar Biotech and Nutrition Ltd (EMMESSA) is ₹64 and the 52-week low is ₹27.25.

  6. What is the PE and PB ratio of Emmessar Biotech and Nutrition Ltd (EMMESSA) stock?

    The P/E (price-to-earnings) ratio of Emmessar Biotech and Nutrition Ltd (EMMESSA) is 21.98. The P/B (price-to-book) ratio is 2.22.

  7. Which sector does Emmessar Biotech and Nutrition Ltd (EMMESSA) belong to?

    Emmessar Biotech and Nutrition Ltd (EMMESSA) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Emmessar Biotech and Nutrition Ltd (EMMESSA) shares?

    You can directly buy Emmessar Biotech and Nutrition Ltd (EMMESSA) shares on Tickertape. Simply sign up, connect your demat account and place your order.